Skip to main content
Premium Trial:

Request an Annual Quote

Gen-Probe, Tosoh Bioscience Cross-License Nucleic Acid Testing IP

NEW YORK, Dec. 9 - Gen-Probe and the Tosoh Bioscience unit of Tokyo-based Tosoh Corp. said today that they have cross-licensed intellectual property covering certain nucleic acid testing technologies.

Tosoh will receive non-exclusive rights to Gen-Probe's transcription-mediated amplification (TMA) and ribosomal RNA technologies in exchange for two payments in 2004. Tosoh will also pay Gen-Probe royalties on worldwide sales of products based on the licensed Gen-Probe technologies.
Gen-Probe will gain access, in exchange for royalties, to Tosoh's patented TRC (t
ranscription reverse-transcription concerted) amplification and INAF (intercalation activating fluorescence) detection technologies for use with real-time TMA.

The licenses are effective Jan. 1, 2004.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more